Literature DB >> 28720763

High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der(1;7)(q10;p10).

T Zhang1, Y Xu1, J Pan1, H Li2, Q Wang1, L Wen1, D Wu1,3, A Sun1, S Chen1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28720763     DOI： 10.1038/leu.2017.228

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.

Authors:  Julie Schanz; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Heinz Tuechler; Peter Valent; Barbara Hildebrandt; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Hagop Kantarjian; Ulrich Germing; Detlef Haase; Elihu Estey
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10).

Authors:  Lili Wang; Seishi Ogawa; Akira Hangaishi; Ying Qiao; Noriko Hosoya; Yasuhito Nanya; Kazuma Ohyashiki; Hideaki Mizoguchi; Hisamaru Hirai
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

3.  Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.

Authors:  Chi-Chiu So; Edmond Shiu-Kwan Ma; Thomas Shek-Kong Wan; Sze-Fai Yip; Li-Chong Chan
Journal:  Leuk Res       Date:  2007-11-05       Impact factor: 3.156

4.  Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.

Authors:  Marilyn L Slovak; Margaret O'Donnell; David D Smith; Karl Gaal
Journal:  Cancer Genet Cytogenet       Date:  2009-09

5.  Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.

Authors:  M Sanada; N Uike; K Ohyashiki; K Ozawa; W Lili; A Hangaishi; Y Kanda; S Chiba; M Kurokawa; M Omine; K Mitani; S Ogawa
Journal:  Leukemia       Date:  2007-02-22       Impact factor: 11.528

6.  RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.

Authors:  V I Gaidzik; V Teleanu; E Papaemmanuil; D Weber; P Paschka; J Hahn; T Wallrabenstein; B Kolbinger; C H Köhne; H A Horst; P Brossart; G Held; A Kündgen; M Ringhoffer; K Götze; M Rummel; M Gerstung; P Campbell; J M Kraus; H A Kestler; F Thol; M Heuser; B Schlegelberger; A Ganser; L Bullinger; R F Schlenk; K Döhner; H Döhner
Journal:  Leukemia       Date:  2016-05-03       Impact factor: 11.528

7.  An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia.

Authors:  J P Geraedts; G J den Ottolander; J E Ploem; O G Muntinghe
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

8.  New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

Authors:  Detlef Haase; Ulrich Germing; Julie Schanz; Michael Pfeilstöcker; Thomas Nösslinger; Barbara Hildebrandt; Andrea Kundgen; Michael Lübbert; Regina Kunzmann; Aristoteles A N Giagounidis; Carlo Aul; Lorenz Trümper; Otto Krieger; Reinhard Stauder; Thomas H Müller; Friedrich Wimazal; Peter Valent; Christa Fonatsch; Christian Steidl
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

9.  IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).

Authors:  M K Westman; J Pedersen-Bjergaard; M T Andersen; M K Andersen
Journal:  Leukemia       Date:  2012-11-29       Impact factor: 12.883

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more
  2 in total

1.  Association of unbalanced translocation der(1;7) with germline GATA2 mutations.

Authors:  Emilia J Kozyra; Gudrun Göhring; Dennis D Hickstein; Katherine R Calvo; Courtney D DiNardo; Michael Dworzak; Valerie de Haas; Jan Starý; Henrik Hasle; Akiko Shimamura; Mark D Fleming; Hiroto Inaba; Sara Lewis; Amy P Hsu; Steven M Holland; Danielle E Arnold; Cristina Mecucci; Siobán B Keel; Alison A Bertuch; Kiran Tawana; Shlomit Barzilai; Shinsuke Hirabayashi; Masahiro Onozawa; Shaohua Lei; Helena Alaiz; Hajnalka Andrikovics; David Betts; Berna H Beverloo; Jochen Buechner; Martin Čermák; José Cervera; Olga Haus; Kirsi Jahnukainen; Kalliopi N Manola; Karin Nebral; Francesco Pasquali; Joelle Tchinda; Dominik Turkiewicz; Nadine Van Roy; Zuzana Zemanova; Victor B Pastor; Brigitte Strahm; Peter Noellke; Charlotte M Niemeyer; Brigitte Schlegelberger; Ayami Yoshimi; Marcin W Wlodarski
Journal:  Blood       Date:  2021-12-09       Impact factor: 22.113

2.  Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q).

Authors:  Ayalew Tefferi; Dame Idossa; Terra L Lasho; Mythri Mudireddy; Christy Finke; Sahrish Shah; Maura Nicolosi; Mrinal M Patnaik; Animesh Pardanani; Naseema Gangat; Curt A Hanson; Rhett P Ketterling
Journal:  Blood Cancer J       Date:  2017-12-18       Impact factor: 11.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.